To speed patient access, Allogene scales up CAR T cell products By starting with T cells from healthy donors, Allogene is manufacturing off-the-shelf CAR T cell therapies that patients don’t have to wait for.

https://www.drugdiscoverynews.com/to-speed-patient-access-allogene-scales-up-car-t-cell-products-16523